iTeos Belgium

4 trials Commercial sponsor

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

0 Recruiting

4 Completed trials

6 Countries active

5 Unique IMPs

100% Results reported

Phase II

Phase I/II

Phase I

Phase II: 1 Phase I/II: 1 Phase I: 2

100%

4 of 4 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Neoplasm 1 Non-small cell lung cancer metastatic 1

Top IMPs

INUPADENANT HYDROCHLORIDE 2 DOSTARLIMAB 1 HUMAN IGG1 KAPPA MONOCLONAL ANTIBODY AGAINST TIGIT 1 INUPADENANT 1 PEMBROLIZUMAB 1

All trials

4 total

A Study of EOS301984 in Adult Participants with Advanced Solid Tumors Ended

2023-503844-14-00 Phase I 1 country
A Multicenter, Open-Label, Phase I/II Study of EOS884448 in combination with standard of care and/or investigational therapies in participan… Ended

2024-512227-36-00 Phase I/II 4 countries DOSTARLIMAB; HUMAN IGG1 KAPPA MONOCLONAL ANTIBODY AGAINST TIGIT; INUPADENANT; IN…
A clinical study evaluating efficacy and safety of inupadenant in combination with carboplatin and pemetrexed in adults with metastatic nons… Ended

2024-515393-27-00 Phase II 6 countries INUPADENANT HYDROCHLORIDE
A Study of EOS006215 in Adult Participants with Advanced Solid Tumors Ended

2024-520369-30-00 Phase I 1 country

Showing 1–4 of 4 trials

← All sponsors A–Z